At the frontier of tomorrow's medicine: understanding stem cells for future cell-based industries

17 May 2019
Meet Australian researchers who use stem cells to advance our understanding of how the body develops and what happens during disease.

Associate Professor Andrew Laslett is the Group Leader of the Laslett Group at the Australian Regenerative Medicine Institute (ARMI) at Monash University and CSIRO. 

Human pluripotent stem cells have the ability of indefinite self-renewal and to differentiate into all types of human adult cells.

The Laslett group investigates the biology of human pluripotent stem cell lines, including embryonic stem cells and human induced pluripotent stem cells – developed cells that have been manipulated to enter a more primitive, less specialised stem cell state.

The group hope that a better understanding of human pluripotent stem cell lines will lead to the development of tools and novel cell lines that will be required for the safe use of these cell types in future cell-based industries.

This is important because although the potential for the treatment of diseases and injuries is huge, the technology also creates a number of risks when producing cell populations to be used for cell therapy.

Listen to A/ Prof Andrew Laslett and his postdoctoral fellow, Dr Jacob Goodwin as they share insights into their research, the joy of leading their own experimental projects and the international opportunities that come from a career in science. 

Australian stem cell researchers are making important discoveries in the lab, that will move research outcomes towards clinical applications. Watch their videos.